Association between Albumin, Total Bilirubin, and Uric Acid Serum Levels and the Risk of Cancer:A Prospective Study in a Korean Population
10.3349/ymj.2021.62.9.792
- Author:
Ye Rim KIM
1
;
Chang Kyun CHOI
;
Young-Hoon LEE
;
Seong-Woo CHOI
;
Hye-Yeon KIM
;
Min-Ho SHIN
;
Sun-Seog KWEON
Author Information
1. Department of Preventive Medicine, Chonnam National University Medical School, Hwasun, Korea
- Publication Type:Original Article
- From:Yonsei Medical Journal
2021;62(9):792-798
- CountryRepublic of Korea
- Language:English
-
Abstract:
Purpose:In this prospective study, we evaluated the association between the serum levels of antioxidants uric acid (UA), albumin, and total bilirubin and the risk of cancer in a Korean population.
Materials and Methods:A total of 15882 subjects were followed up for cancer development and cancer-related death. During the follow-up period, 1619 cancer diagnoses and 617 cancer-related deaths were recorded. Cox proportional regression was performed to calculate the hazard ratio (HR) per standard deviation (SD) increment and 95% confidence interval (CI). The model was adjusted for covariates such as the age, sex, smoking, alcohol consumption, physical activity, education level, body mass index, and family history. Sensitivity analyses using the study subjects with physiological serum levels of each indicator were also performed.
Results:UA levels were positively correlated with cancer risk (HR per SD increment 1.04; 95% CI, 1.01–1.09), and albumin levels were inversely associated with the overall cancer risk (HR, 0.92; 95% CI, 0.88–0.96) and cancer-related death (HR, 0.86; 95% CI, 0.80–0.93). Total bilirubin levels were negatively correlated with the risk of cancer-related death (HR, 0.91; 95% CI, 0.83–0.99). By cancer type, UA was positively associated with prostate cancer, total bilirubin was positively associated with liver cancer, and albumin was inversely associated with lung cancer.
Conclusion:The findings of this study support the role of antioxidants in carcinogenesis. Future large-cohort studies are needed to confirm the predictive value of albumin, UA, and total bilirubin levels in each type of cancer.
